Physician

John Bretton Brantley, MD

According to 2025 Medicare claims, John Brantley, MD (NPI: 1629006630) practices dermatology in the Baton Rouge, LA market, with the plurality of this provider's patient population coming from E. Baton Rouge, LA. This provider's primary affiliated billing organization is CALAIS DERMATOLOGY ASSOCIATES (NPI: 1093742769; TIN: 720719971) and primary practice location at 70808-9112.

Brantley's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,130 traditional Medicare patients, billed 9,099 HCPCS/CPT codes, and received $358,208 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 2,941 prescription claims across 1,132 beneficiaries totaling $722,442 in drug costs, led by Erivedge (Vismodegib). Open Payments data shows 127 records totaling $2,333. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $99,910 to $722,442. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$183K$366K2015 Medicare payment: $273,693 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $291,723 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $310,214 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $323,071 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $320,273 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $294,647 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $354,823 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $365,975 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $355,860 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $358,208 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,0299,398$273,693
20169929,253$291,723
20171,0979,761$310,214
20181,13510,057$323,071
20191,24310,022$320,273
20201,1218,966$294,647
20211,0898,988$354,823
20221,1559,772$365,975
20231,1559,366$355,860
20241,1309,099$358,208

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$361K$722K2015 Drug cost: $99,910 (USD; Tot_Drug_Cst)2016 Drug cost: $125,076 (USD; Tot_Drug_Cst)2017 Drug cost: $161,918 (USD; Tot_Drug_Cst)2018 Drug cost: $331,385 (USD; Tot_Drug_Cst)2019 Drug cost: $352,172 (USD; Tot_Drug_Cst)2020 Drug cost: $568,275 (USD; Tot_Drug_Cst)2021 Drug cost: $497,131 (USD; Tot_Drug_Cst)2022 Drug cost: $613,569 (USD; Tot_Drug_Cst)2023 Drug cost: $674,240 (USD; Tot_Drug_Cst)2024 Drug cost: $722,442 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20155751,445$99,910
20166431,672$125,076
20177732,199$161,918
20188442,307$331,385
20199562,510$352,172
20209622,886$568,275
20211,0192,869$497,131
20221,0252,841$613,569
20231,0292,756$674,240
20241,1322,941$722,442

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths386493$75
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more8941,694$59
11102Biopsy of related skin growth, first growth423547$59
17000Destruction of precancer skin growth, 1 growth6131,011$36
17003Destruction of precancer skin growth, 2-14 growths5043,505$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ErivedgeVismodegib11308$150,806
Dupixent SyringeDupilumab14392$52,396
FluorouracilFluorouracil1824,702$11,053
IvermectinIvermectin11315$3,941
Betamethasone DipropionateBetamethasone Dipropionate771,911$3,647

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.127$2,333ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for John Bretton Brantley, MD?

Tedicare shows public-source Medicare data for John Bretton Brantley, MD (NPI 1629006630), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John Bretton Brantley, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John Bretton Brantley, MD?

John Bretton Brantley, MD is linked to CALAIS DERMATOLOGY ASSOCIATES (billing NPI 1093742769) in the available physician profile data.

Does John Bretton Brantley, MD have Open Payments data?

John Bretton Brantley, MD has 127 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.